RIPE-KG · Version 1.1.0 · Resource

ripekg:work/10.1111%2Fjsr.13387

https://w3id.org/ripe/ripe-kg/work/10.1111%2Fjsr.13387
SubjectPredicateObject
ripekg:work/10.1111%2Fjsr.13387European guideline and expert statements on the management of narcolepsy in adults and children prism:doi 10.1111/jsr.13387
ripekg:work/10.1111%2Fjsr.13387European guideline and expert statements on the management of narcolepsy in adults and children dcterms:title European guideline and expert statements on the management of narcolepsy in adults and children
ripekg:work/10.1111%2Fjsr.13387European guideline and expert statements on the management of narcolepsy in adults and children rdf:type node1
ripekg:work/10.1111%2Fjsr.13387European guideline and expert statements on the management of narcolepsy in adults and children rdf:type http://purl.org/spar/fabio/Work
ripekg:work/10.1111%2Fjsr.13387European guideline and expert statements on the management of narcolepsy in adults and children rdf:type rdfs:Resource
ripekg:work/10.1111%2Fjsr.13387European guideline and expert statements on the management of narcolepsy in adults and children rdf:type owl:Thing
ripekg:work/10.1111%2Fjsr.13387European guideline and expert statements on the management of narcolepsy in adults and children rdf:type prov:Entity
ripekg:work/10.1111%2Fjsr.13387European guideline and expert statements on the management of narcolepsy in adults and children rdf:type ripe:WorkWork
ripekg:work/10.1111%2Fjsr.13387European guideline and expert statements on the management of narcolepsy in adults and children owl:sameAs https://semopenalex.org/work/W4226449638
ripekg:work/10.1111%2Fjsr.14373Pitolisant 40 mg for excessive daytime sleepiness in obstructive sleep apnea patients treated or not by <scp>CPAP</scp>: Randomised phase 3 study http://purl.org/spar/cito/cites ripekg:work/10.1111%2Fjsr.13387European guideline and expert statements on the management of narcolepsy in adults and children